$Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Extramedullary Multiple Myeloma: A Conditioning Regimen Combining Selinexor and Helical Tomotherapy—A Case Report and Literature Review$

Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Extramedullary Multiple Myeloma: A Conditioning Regimen Combining Selinexor and Helical Tomotherapy—A Case Report and Literature Review

Bin Chen, Rongrong Guo, Yanyan Niu, Wei Guo, Tao Wang Department of Hematology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, People’s Republic of ChinaCorrespondence: Tao Wang, Email wangtao99699@16...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen B, Guo R, Niu Y, Guo W, Wang T
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-04-01
Series:	Journal of Blood Medicine
Subjects:	allogeneic hematopoietic stem cell transplantation relapsed/refractory multiple myeloma； extramedullary multiple myeloma selinexor tomotherapy
Online Access:	https://www.dovepress.com/haploidentical-hematopoietic-stem-cell-transplantation-for-relapsedref-peer-reviewed-fulltext-article-JBM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease
by: Junjing Yin, et al.
Published: (2024-11-01)

Real-World Treatment Patterns and Survival Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with a Selinexor-Containing Triplet-Based Regimen
by: Andrew Whiteley, et al.
Published: (2025-05-01)

A case report of relapsed and refractory multiple myeloma with multifocal extramedullary infiltration and pulmonary adenocarcinoma
by: DU Fang, et al.
Published: (2025-01-01)

Selinexor’s Immunomodulatory Impact in Advancing Multiple Myeloma Treatment
by: Kereshmeh Tasbihi, et al.
Published: (2025-03-01)

Subglottic extramedullary plasmacytoma in a patient with multiple myeloma
by: Eva M. Ruis de Gauna Martin, et al.
Published: (2013-03-01)

Presentation of extramedullary myeloma manifestations on B-mode (B-US) and contrast-enhanced ultrasound (CEUS)
by: Trenker Corinna, et al.
Published: (2025-05-01)

Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia‐Induced Vulnerabilities in Multiple Myeloma
by: Seiichi Okabe, et al.
Published: (2025-06-01)

BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
by: Hao Yao, et al.
Published: (2025-05-01)

Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor
by: Junying Wang, et al.
Published: (2025-01-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

Pulmoner extramedullary hematopoiesis mimicking plasmacytoma in a patient with multiple myeloma candidate for autoHSCT
by: Serdar Sivgin
Published: (2014-08-01)

Extramedullary Disease of the Breast in Multiple Myeloma—An Uncommon Initial Presentation: A Case Report and Review of Literature
by: Priyadarshini Venkataraman, et al.

Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma
by: A P Dubey, et al.
Published: (2020-01-01)

Multiple Myeloma Concurrent with Extramedullary Plasmacytoma of the Breast: A Case Report and Literature Review
by: LIU Yuhan, et al.
Published: (2025-07-01)

Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease
by: Vanessa Desantis, et al.
Published: (2025-04-01)

Extramedullary Plasmacytoma of the Oral Cavity: A Rare Case in the Buccal Mucosa
by: Armin Khaleghi, et al.
Published: (2025-01-01)

Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti‐CD38 Monoclonal Antibodies: A Systematic Review
by: Chia Jie Tan, et al.
Published: (2025-03-01)

Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world data
by: Ning Lyu, et al.
Published: (2025-01-01)

COMMD3 Regulates Copper Metabolism via the ATOX1-ATP7A-LOX Axis to Promote Multiple Myeloma Progression
by: Yajun Wang, et al.
Published: (2025-02-01)

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group
by: Jiri Minarik, et al.
Published: (2025-04-01)

Case Report: BCMA-targeting CAR T-cell therapy induces complete and durable remission in relapsed extramedullary plasmablastic multiple myeloma
by: Lili Zhou, et al.
Published: (2025-05-01)

Anaplastic Multiple Myeloma Presenting as Acute Liver Failure: A Case Report
by: Yasmin O. Ali, et al.
Published: (2025-01-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease
by: Juan Xu, et al.
Published: (2025-05-01)

Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature
by: S. V. Semochkin
Published: (2015-10-01)

Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy
by: Goel U, et al.
Published: (2025-02-01)

Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM)
by: Josip Batinić, et al.
Published: (2024-11-01)

The Multiple Myeloma
by: Keivan Daneshvar, et al.
Published: (2024-03-01)

A rare presentation of multiple myeloma with concurrent paraskeletal extramedullary thoracic plasmacytoma: A case report
by: Saja I. AbuGhannam, et al.
Published: (2025-01-01)

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
by: Barry Paul, et al.
Published: (2025-06-01)

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01)

Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial
by: Ya‐Lan Zhou, et al.
Published: (2025-04-01)

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)
by: Ayman Alhejazi, et al.
Published: (2025-05-01)

Unexpected hope for a multiple myeloma patient
by: Minodora Cezarina Onisâi, et al.
Published: (2020-10-01)

Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01)

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Clinical case of giant extramedullar plasmacytoma in a patient with multiple myeloma
by: G. Sh. Safuanova, et al.
Published: (2023-12-01)

Fatigue as main symptom in an elderly multiple myeloma patient: a Case Report
by: Xuanna Li, et al.
Published: (2025-08-01)

The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy
by: Lingling Yin, et al.
Published: (2025-04-01)